Goetz, Christopher G.

MDS clinical diagnostic criteria for Parkinson’s disease

Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 7,653

Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results

Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez‐Martin, P., Poewe, W., Sampaio, C., Stern, M. B., Dodel, R., et al. (2008) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 7,536

Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium

McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 5,069

Clinical diagnostic criteria for dementia associated with Parkinson’s disease

Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 3,027

The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease

Seppi, K., Weintraub, D., Coelho, M., Perez‐Lloret, S., Fox, S. H., Katzenschlager, R., Hametner, E., Poewe, W., Rascol, O., Goetz, C. G., et al. (2011) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 1,141

DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers

Lippa, C. F., Duda, J. E., Grossman, M., Hurtig, H. I., Aarsland, D., Boeve, B. F., Brooks, D. J., Dickson, D. W., Dubois, B., Emre, M., et al. (2007) · Neurology

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 548

Diagnostic criteria for psychosis in Parkinson's disease: Report of an NINDS, NIMH work group

Ravina, B., Marder, K., Fernandez, H. H., Friedman, J. H., McDonald, W., Murphy, D., Aarsland, D., Babcock, D., Cummings, J., Endicott, J., et al. (2007) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsHallucinations in medical conditions

Cited by 528

Age at Onset in Two Common Neurodegenerative Diseases Is Genetically Controlled

Li, Y.-J., Scott, W. K., Hedges, D. J., Zhang, F., Gaskell, P. C., Nance, M. A., Watts, R. L., Hubble, J. P., Koller, W. C., Pahwa, R., et al. (2002) · The American Journal of Human Genetics

Alzheimer's disease research and treatmentsGenetic Associations and Epidemiology

Cited by 312

Hallucinations in Parkinson disease

Diederich, N. J., Fénelon, G., Stebbins, G., & Goetz, C. G. (2009) · Nature Reviews Neurology

Hallucinations in medical conditionsParkinson's Disease Mechanisms and Treatments

Cited by 312

TikTok Tics: A Pandemic Within a Pandemic

Olvera, C., Stebbins, G. T., Goetz, C. G., & Kompoliti, K. (2021) · Movement Disorders Clinical Practice

Obsessive-Compulsive Spectrum DisordersSocial Media in Health Education

Cited by 158

Apolipoprotein E controls the risk and age at onset of Parkinson disease

Li, Y. J., Hauser, M. A., Scott, W. K., Martin, E. R., Booze, M. W., Qin, X. J., Walter, J. W., Nance, M. A., Hubble, J. P., Koller, W. C., et al. (2004) · Neurology

Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatments

Cited by 144

An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson’s disease participants

Hall, D. A., Voigt, R. M., Cantu-Jungles, T. M., Hamaker, B., Engen, P. A., Shaikh, M., Raeisi, S., Green, S. J., Naqib, A., Forsyth, C. B., et al. (2023) · Nature Communications

Parkinson's Disease Mechanisms and TreatmentsGut microbiota and health

Cited by 124

Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies

Goldman, J. G., Goetz, C. G., Brandabur, M., Sanfilippo, M., & Stebbins, G. T. (2008) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 109

Tremor and ataxia in fragile X premutation carriers: Blinded videotape study

Berry‐Kravis, E., Lewin, F., Wuu, J., Leehey, M., Hagerman, R., Hagerman, P., & Goetz, C. G. (2003) · Annals of Neurology

Genetics and Neurodevelopmental DisordersGenetic Neurodegenerative Diseases

Cited by 109

Visual plus nonvisual hallucinations in Parkinson's disease: Development and evolution over 10 years

Goetz, C. G., Stebbins, G. T., & Ouyang, B. (2011) · Movement Disorders

Hallucinations in medical conditionsParkinson's Disease Mechanisms and Treatments

Cited by 91

Understanding visual hallucinations: A new synthesis

Collerton, D., Barnes, J., Diederich, N. J., Dudley, R., ffytche, D., Friston, K., Goetz, C. G., Goldman, J. G., Jardri, R., Kulisevsky, J., et al. (2023) · Neuroscience & Biobehavioral Reviews

Hallucinations in medical conditionsVisual perception and processing mechanisms

Cited by 83

Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status

Voigt, R. M., Wang, Z., Brown, J. M., Engen, P. A., Naqib, A., Goetz, C. G., Hall, D. A., Metman, L. V., Shaikh, M., Forsyth, C. B., et al. (2022) · Neurobiology of Disease

Parkinson's Disease Mechanisms and TreatmentsGut microbiota and health

Cited by 51